Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision
NCT: NCT07844681 · NOT_YET_RECRUITING
Brief Summary
This study will compare surgical site infection after linear repair with or without cyanoacrylate skin adhesive following Mohs micrographic surgery or wide local excision. Adult participants undergoing Mohs micrographic surgery or wide local excision for skin cancer with a surgical defect suitable for linear repair will be stratified by suture type and randomized to standardized running epidermal suture closure with or without cyanoacrylate skin adhesive. The primary outcome is surgical site infection within 30 days after surgery. Secondary outcomes include scar quality, treatment satisfaction, wound care burden, wound healing characteristics, antibiotic use, culture results, health care utilization related to wound concerns, and adverse events.
Frequently Asked Questions
What is Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision?
Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision is a clinical trial registered under NCT07844681. Current status: NOT_YET_RECRUITING.
What is the status of NCT07844681?
The current status of NCT07844681 (Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision) is: NOT_YET_RECRUITING.
When did Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision start?
Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision started on 2026-10-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.